You are here

Drug levels: the future of personalised therapy?

Séverine Vermeire

IBD-S-Vermeire-Intro-Summary

Séverine Vermeire presents therapeutic drug and antibody monitoring as a helpful tool in optimizing and personalising the management of patients treated with anti-TNFs, especially when employed early after induction.  

Watch the full IBD12 presentation

Drug levels:the future of personalized therapy?

Séverine Vermeire

Share

E-Alert

Subscribe to our E-Alert to stay informed of all new content as it's published on this platform.

IBD 13.03.2015

Visit the journal website!

Search form